Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/6/26 16:15 | 4/2/26 | KROS | Health | Drug | Pharmaceutical Preparations | Seehra Jasbir | MA | DO | CEO | 2 | M.d | 130 | 2.10 | 0 | 62 | 16 | 441 | D | ||||||||||||||
3/11/26 16:33 | 3/9/26 | KROS | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | MA | D | 1 | P | 22 | 11.21 | 0 | 2 | 37 | 7 | D | |||||||||||||||
2/20/26 16:15 | 2/18/26 | KROS | Health | Drug | Pharmaceutical Preparations | Lerner Lorena Raquel | MA | O | Chief Sc | 1 | S | -63 | 16.35 | 0 | -4 | 31 | D | |||||||||||||||
2/20/26 16:15 | 2/18/26 | KROS | Health | Drug | Pharmaceutical Preparations | Cho Esther | MA | O | SVP,GC | 1 | S | -78 | 16.35 | 0 | -5 | 40 | D | |||||||||||||||
2/20/26 16:15 | 2/18/26 | KROS | Health | Drug | Pharmaceutical Preparations | Regnante Keith | MA | O | CFO | 1 | S | -77 | 16.35 | 0 | -5 | 39 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |